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Descriptive Epidemiology of Cholangiocarcinoma and 
Clonorchiasis in Korea
In 2009, infection with the liver fluke Clonorchis sinensis (C. sinensis) was classified as 
“carcinogenic to humans” (Group 1) based on its involvement in the etiology of 
cholangiocarcinoma by the International Agency for Research on Cancer. However, little is 
known about the descriptive epidemiology of cholangiocarcinoma in Korea. We examined 
incidence trends of intrahepatic and extrahepatic cholangiocarcinomas, using data from 
the Korea National Cancer Incidence database for 1999-2005. The prevalence of C. sinensis 
infection was estimated from a recent population-based survey in rural endemic areas. 
Cholangiocarcinoma incidence rates are currently rising, even while primary liver cancer 
incidence rates are decreasing. Annual percent changes in cholangiocarcinoma incidence 
rates were 8% for males and 11% in females. Known areas of C. sinensis endemicity 
showed high incidence rates of cholangiocarcinoma. The positivity of C. sinensis eggs in 
stool samples from endemic areas was more than 25% of adults tested during 2005-2008. 
From a meta-analysis, the summary odds ratio for cholangiocarcinoma due to C. sinensis 
infection was 4.7 (95% confidence interval: 2.2-9.8). Approximately 10% of 
cholangiocarcinomas in Korea were caused by chronic C. sinensis infections. More specific 
policies, including health education and an extensive effort for early detection in endemic 
areas, are needed.
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INTRODUCTION
The two liver flukes Clonorchis sinensis (C. sinensis) and Opis-
thorchis viverrini (O. viverrini) are members of the Opisthorchi-
idae family (1). These species are considered to be of major so-
cial and economic relevance for both humans and animals in 
Asian countries including China, Korea, Vietnam, Laos, and 
Thailand (2). In 1994, infection with O. viverrini was classified 
by the International Agency for Research on Cancer (IARC) as 
“carcinogenic to humans” (Group 1) based on its involvement 
in the etiology of cholangiocarcinoma (CCA). Alternatively, in-
fection with C. sinensis was classified as “probably carcinogenic 
to humans” (Group 2A) because there was only limited evidence 
for the carcinogenicity of this worm in humans (3).
  In Volume 100B from February of 2009, the IARC Monograph 
Working Group reassessed the carcinogenicity of infection with 
liver flukes by applying a comprehensive review of all of the avail-
able published literature (4). Prevalence of infection with C. si-
nensis was shown to correlate with the incidence of CCA (5), and 
several case–control studies showed a high risk for this cancer 
(6-8).
  Therefore, infections with O. viverrini and C. sinensis are now 
both classified in Group 1 by the IARC, based on “sufficient evi-
dence in humans” for CCA.
  Beginning in the 1970’s, several papers reported a high cor-
relation between CCA and clonorchiasis in the southern part of 
the Korean Peninsula (9, 10).
  However, little is known about the existing distribution and 
trend of incidence, and related risk factors of CCA in Korea, a 
nation where C. sinensis infection is highly prevalent.
  In the present paper, incidence rates of CCA and the preva-
lence of infection with C. sinensis are described in an attempt to 
evaluate the burden of CCA related to infection with C. sinensis 
in Korea.
MATERIALS AND METHODS
Incidence of CCA
We extracted intrahepatic CCA cases (International Classifica-
tion of Disease (ICD) 10 code C22.1 (11), ICD-Oncology (ICD-
O) (12) code 8160, including adenocarcinoma (ICD-O codes 
8140, 8161, 8260, 8440, 8480, and 8560), duct carcinoma (ICD-O 
code 8500), and Klatskin tumor (ICD-O codes 8162), and extra-
hepatic CCA: ICD 10 code C24.0) from the Korea National Can-Shin H-R, et al.  •  Epidemiology of Cholangiocarcinoma and Clonorchiasis in Korea
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cer Incidence Database (KNCIDB). We examined all of the re-
cords of CCA reported from 1999 through 2005. Next, we com-
puted the age-standardized incidence rates per 100,000 person-
years on the basis of the world standard population. To com-
pare changes in incidence between 1999 and 2005, we calculat-
ed the estimated annual percentage change (EAPC). Incidence 
rates were separately analyzed by sex and region for two calen-
dar periods (1999-2002 and 2003-2005) because Korean nation-
al incidence rates in Cancer Incidence in Five Continents vol-
ume 9 published by IARC covered the 1999-2002 period and the 
incidence rates for 2003-2005 were published in 2009 (13, 14).
Prevalence of C. sinensis infection from 2005-2008
During 2005-2008, a total of 4,234 subjects (age range: 30–89; 
mean age: 59.9 yr) were recruited as a part of population-based 
cohort construction in areas of Haman and Sanchong in Gyeong-
sangnam-do which was known endemic of C. sinensis; from the 
basin of the Nakdong River. A trained research assistant inter-
viewed each participant about the demographic characteristics, 
alcohol drinking and tobacco smoking habits, dietary habits in-
cluding raw fresh-water fish, and disease history. Stool samples 
were also collected for laboratory examination. Additionally, 
informed consent was obtained from all participants, and the 
study protocol was approved by the National Cancer Center of 
Korea.
  Stool samples were examined using the formalin-ether sedi-
mentation method to identify the presence of C. sinensis eggs. 
Also, data from national surveys of intestinal parasites from 1971 
(1st report) to 2004 (7th report) were used for an estimation of 
the population-attributable fraction.
Summary risk of C. sinensis infection with CCA and 
population attributable fraction calculation
Using published data from cross-sectional (9, 10) and case-con-
trol studies (6-8) of CCA with C. sinensis infection, meta-analy-
sis was performed to estimate the risk of CCA. Pooled odds ra-
tios (ORs) with 95% confidence intervals (CIs) were estimated 
on the basis of both fixed- and random-effect models. Hetero-
geneity analysis was then carried out to verify if there was a sig-
nificant difference between studies. The Stata version 10.0 (Stata-
Corp, TX, USA) and Comprehensive Meta-Analysis version 2 
(Biostat, NJ, USA) software programs were used for the meta-
analysis. Using the formula below, the attributable fraction was 
estimated using information about the prevalence of C. sinensis 
infection in 1981 (15) and relative risk estimates from meta-anal-
ysis. The calculated attributable fraction was applied to the num-
ber of incidence cases of CCA in 2005 in consideration of the la-
tency period.
Population-attributable fraction=
         C. sinensis prevalence×(summary odds ratio-1)      
×100
       C. sinensis prevalence×(summary odds ratio-1)+1
RESULTS
Incidence of intrahepatic CCA
Since 1999, the annual average incidence of primary liver can-
cer was 10,500 cases for males and 3,500 cases for females. In 
addition, a decreasing trend was observed, with an EAPC of ap-
proximately -2%. Intrahepatic CCA accounted for approximately 
10% of liver cancers (8.8% for males and 10.6% for females) and 
this proportion increased by year, with levels of 11.6% for males 
and 22.7% for females in 2005. Intrahepatic CCA rates increased 
gradually from 2001 (with EAPCs of 7.9% and 10.6% for males and 
females, respectively); however, the extrahepatic CCA rates were 
stable during the same period (Table 1). There were approxima–
tely 2.5- to 3.0-fold variations by region, with Gyeongsangnam-do 
having the highest incidence rates for males (Table 2). The increase 
in the incidence of female cases (168.6%) was higher than that 
seen for males (149.7%) in recent years (2003-2005) compared 
to the earlier years examined (1999-2002). Very sharp increases 
in cases involving both males and females age 50 and over were 
observed during the time period of 2003 thro–ugh 2005 (Fig. 1).
Prevalence of C. sinensis infection in the Gyeongsangnam-
do area in 2005-2008
Overall C. sinensis egg positivity in stool was measured at 28.2% 
(27.6% in 2005; 34.5% in 2006; 25.4% in 2007; 21.7% in 2008) 
among adults ages 30 and over (the age-standardized preva-
lence rates were 35.0% and 20.8% for males and females, respec-
Table 1. Number of cases and age-standardized incidence rates of liver cancer (C22), 
intrahepatic cholangiocarcinoma (C22.1), and extrahepatic cholangiocarcinoma (C24.0) 
in Korea, 1999-2005
Year
Sex
Site
Male Female
Liver
C22
Cases
(ASR)
ICCA
C22.1
Cases
(ASR)
ECCA
C24.0
Cases
(ASR)
Liver
C22
Cases
(ASR)
ICCA
C22.1
Cases
(ASR)
ECCA
C24.0
Cases
(ASR)
1999 10,027
(46.8)
  733
(3.6)
683
(3.6)
3,259
(12.3)
367
(1.4)
443
(1.6)
2000   9,898
(44.7)
  648
(3.1)
652
(3.3)
3,228
(11.8)
403
(1.5)
477
(1.6)
2001 10,433
(45.1)
  770
(3.5)
737
(3.6)
3,435
(12.2)
389
(1.4)
506
(1.7)
2002 10,490
(43.9)
  906
(3.9)
712
(3.3)
3,471
(11.8)
536
(1.8)
496
(1.6)
2003 10,586
(42.3)
961
(4.1)
752
(3.4)
3,501
(11.5)
617
(2.0)
568
(1.7)
2004 10,880
(42.0)
1,164
(4.8)
856
(3.7)
3,542
(11.2)
699
(2.2)
586
(1.7)
2005 11,264
(42.0)
1,307
(5.2)
859
(3.6)
3,643
(11.1)
828
(2.5)
612
(1.7)
Total
   (average)
10,511
(43.7)
  927
(4.1)
750
(3.5)
3,440
(11.7)
548
(1.8)
527
(1.7)
APC %  -1.8 7.9 0.3 -1.7 10.6 1.3
Proportion  8.8% 15.9%
ASR, age-standardized incidence rates; APC, annual percent change; ICCA, intrahe–
patic cholangiocarcinoma; ECCA, extrahepatic cholangiocarcinoma.Shin H-R, et al.  •  Epidemiology of Cholangiocarcinoma and Clonorchiasis in Korea
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tively). A higher prevalence was observed in the 40- to 59-yr-old 
age group in both males and females (Table 3).
Risk estimates for CCA according to C. sinensis infection 
status and population-attributable fraction based on 
Korean studies
Table 4, Fig. 2 illustrate the risk estimates for CCA according to 
C. sinensis infection status. The overall odds ratio for CCA due 
to C. sinensis infection was 4.7 (95% CI: 2.2-9.8). In 2005, 9.5% of 
CCA cases were attributable to infection with C. sinensis (12.2% 
for males, 5.5% for females) (Table 5). In the endemic areas, the 
population-attributable fraction was much higher, at levels of 
27.9% and 16.2% for males and females, respectively.
Table 2. Age-standardized incidence rates of cholangiocarcinoma (CCA) by region in Korea over two time periods: 1999-2002 and 2003-2005
Regions
Intrahepatic CCA Extrahepatic CCA
Male Female Male Female
99-02 03-05 99-02 03-05 99-02 03-05 99-02 03-05
Overall 3.5 4.7 1.5 2.2 3.5 3.5 1.6 1.7
Seoul 2.6 3.6 1.4 2.0 2.6 2.9 1.4 1.4
Busan 3.5 5.3 1.9 2.6 4.0 4.1 2.4 2.2
Daegu 4.5 5.7 1.7 2.5 4.8 4.0 2.2 2.3
Incheon 3.5 3.6 1.5 2.1 3.1 3.2 1.3 2.0
Gwangju 4.3 6.7 1.4 2.4 4.6 6.0 1.8 2.4
Daejeon 3.3 4.6 1.2 1.8 2.9 3.6 1.5 2.0
Ulsan 5.1 5.4 1.6 2.3 4.5 3.1 1.7 2.0
Gyeounggi-do 2.8 3.5 1.4 1.8 2.9 2.9 1.4 1.3
Gangwon-do 2.0 2.9 0.9 1.7 3.0 2.5 1.0 1.2
Chungcheongbuk-do 3.7 4.5 1.6 2.4 2.5 2.9 1.4 1.9
Chungcheongnam-do 3.1 4.1 1.6 1.8 2.9 2.9 1.2 1.2
Jeollabuk-do 5.3 6.0 1.6 2.1 4.0 3.7 1.8 1.6
Jeollanam-do 3.2 5.8 1.8 2.6 3.8 4.3 1.8 2.3
Gyeongsangbuk-do 3.7 5.7 1.3 2.5 4.3 4.4 1.8 1.6
Gyeongsangnam-do 7.2 8.5 2.1 3.0 4.8 5.3 1.9 2.4
Jejudo 3.1 5.0 2.0 3.2 4.4 3.1 2.5 1.6
National Cancer Incidence Database, Korea Central Cancer Registry, National Cancer Center, Korea.
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Fig. 1. Age specific incidence rates of cholangiocarcinoma by sex for 1999-2000 and 2003-2005. (A) Intrahepatic, (B) Extrahepatic.
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Table 3. Prevalence of Clonorchis sinensis among residents in the endemic area, Gyeongsangnam-do: 2005-2008
Age group
Total Male Female
No. examined Egg pos. (%) No. examined Egg pos. (%) No. examined Egg pos. (%)
30-39   174      28 (16.1)      51   11 (21.6)    123   17 (13.8)
40-49   489   168 (34.4)    202   93 (46.0)    287   75 (26.1)
50-59 1,037    315 (30.4)    447 174 (38.9)    590 141 (23.9)
60-69 1,632    463 (28.4)    588 223 (37.9) 1,044 240 (23.0)
70+    902    218 (24.2)    374 119 (31.8)    528   99 (18.8)
Total 4,234 1,192 (28.2) 1,662 620 (37.3) 2,572 572 (22.2)
Age-standardized
   proportion (95% CI)*
26.3 (23.9-28.8) 35.0 (34.9-35.1) 20.8 (20.7-20.9)
*Age-standardized proportion to the population in Kyeongsang Nam-do in 2005. Shin H-R, et al.  •  Epidemiology of Cholangiocarcinoma and Clonorchiasis in Korea
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DISCUSSION
The age-standardized incidence rates of intrahepatic CCA in Ko-
rea were 4.1 per 100,000 males and 1.8 per 100,000 females, re-
spectively, from 1999 to 2005 and these are between two and four 
times higher than those in the United States (e.g., in the 1996-2000 
period, White males, 0.92/100,000; Black males, 0.93/100,000; 
White females, 0.57/100,000; Black females, 0.39/100,000) (16) 
and England and Wales (e.g., in the 1999-2001 period, males, 
1.33/100,000; females, 1.06/100,000) (17). Increases in intrahe-
patic CCA were observed in our study, correlating well with stud-
ies conducted in the United States, England, and Wales (16, 17). 
The reasons for increases in CCA incidence are not clear. Some 
part of this increase may be attributed to changes in the coding 
system, from ICD-O-2 to ICD-O-3, but these changes were not 
drastic (18). More rapid increases among the elderly might be 
attributed to complete and accurate cancer registration (14). The 
CCA incidence was higher in males than in females but the in-
crease in CCA incidence was bigger in females than in males. 
This might be caused that the greater percent change due to rel-
atively small numbers of CCA case in females than in males. It 
needs further studies. 
  Since 1971, national surveys of intestinal parasitic infections 
have monitored the overall prevalence of C. sinensis in Korea 
Table 4. Summary of study characteristics for cholangiocarcinoma according to Clonorchis sinensis infection status in Korea
Reference Study design and place
Case Control
Characteristics
N
C. sinensis 
positive
N
C. sinensis
positive
Kim, 1974 (9) Cross-sectional study, Seoul National University, 
Hospital, Seoul and Pusan (Busan) Gospel Hospital,  
Busan, 1961-1972
  54 21 1,348 120 Cases: CCA
Control: HCC cases
Crude OR
Chung & Lee,  
   1976 (10)
Cross-sectional study, Pusan National University,
Hospital, Busan, 1964-1974
  36 19   559
 
  88 Cases: CCA
Frequency matched control from the 
patients admitted in the study hospital with 
no liver cancer
Crude OR
Shin, 1996 (6) Hospital based case-control study
Pusan (Busan) Paik Hospital, Busan, 1990-1993
  36 12    350   44 Cases: CCA
Adjusted OR
Choi, 2006 (7) Hospital based case-control study
Samsung Medical Center, Seoul, 2003-2004
164 25    164   11 Cases: Intrahepatic, hilar, extrahepatic CCA
Adjusted OR
Lee, 2008 (8) Hospital based case-control study
Asan Medical Center, Seoul, 2000-2004
622 26 2,488     9 Cases: Intrahepatic CCA
Adjusted OR
CCA, cholangiocarcinoma; HCC, hepatocellular carcinoma; OR, odds-ratio.
Table 5. Clonorchis sinensis infection-attributable cholangiocarcinoma in Korea, 2005
Sex No. of CCA cases
Prevalence of 
C. sinensis
Population 
Attributable
Fraction to  
C. sinensis (%)
Application for overall 
cases in 2005
Nationwide %  
in 1981*
Male
Female
Both sex
2,166
1,440
3,606
3.8
1.6
12.2
  5.5
  9.5
Application for cases
† 
 in Gyeongsang-  
nam-do in 2005
% in Gyeongsang-
nam-do, 1981
‡
Male
Female
Both sex
   250
   161
   411
10.6
  5.3
27.9
16.2
22.6
*C. sinensis prevalence in 1981 (Total=2.6%, M=3.8%, F=1.6%) (Ref [15]); 
†cases 
with patients age 30 or over; 
‡% among patients age 30 or over.
(Source: Prevalence of intestinal parasitic infections in Korea: the 3rd report. The Mini–
stry of Health and Social Affairs. The Korea Association of Parasite Eradication. 1981).
CCA, cholangiocarcinoma.
Fig. 2. Risk estimates for cholangiocarcinoma according to Clonorchis sinensis infection status.
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(15). Areas heavily endemic for clonorchiasis in Korea are scat-
tered throughout the country, with the most extensive and in-
tensive endemic regions found mainly along the Nakdong River 
and the lower reaches of the rivers located in Gyeongsangnam-do 
(19). The infection status of C. sinensis has shown little change 
over 25 yr, despite the development of effective antihelminthics 
such as praziquantel. The repeated consumption of fresh-water 
fish is one of the main contributing factors for the high prevalence 
of clonorchiasis, even after intervention with praziquantel (5).
  In an ecological study conducted during 2000-2004 in Korea, 
C. sinensis prevalence (2.1% in Chuncheon, 7.8% in Chungju, 
and 31.3% in Haman) correlated strongly with CCA incidence 
rates (0.3, 1.8, and 5.5 per 100,000 persons, respectively) (5).
  In Korea, the national liver cancer surveillance program for 
high-risk patients began in 2002 and is comprised of carriers of 
hepatitis B virus or C virus. Any individuals with current or pri-
or C. sinensis infection are also part of the high-risk group for the 
contraction of primary liver cancer in areas endemic for C. si-
nensis. Therefore, these high-risk individuals should be includ-
ed in the surveillance program.
  Apart from clonorchiasis, a main risk factor of CCA, the other 
known risk factors include chronic infection with hepatitis B and 
C viruses (HBV and HCV), liver cirrhosis, chronic non-alcohol-
ic liver disease, obesity and hepatolithiasis (4, 20, 21). A possible 
association between HBV and HCV–known to cause hepatocel-
lular carcinoma– and CCA was reported by IARC as there is only 
limited human evidence (4). Both intrahepatic CCA and extra-
hepatic CCA are well-known complications of Primary Scleosing 
Cholangitis (PSC) in Western countries (22).
  Among these risk factors, hepatolithiasis is a very uncommon 
disease in the West, in contrast, intra- and extrahepatic bile duct 
stones are much more common in Eastern Asia (23). Hepatoli-
thiasis is strongly associated with CCA with proportions varying 
from 10% in Japan, 35% in Korea to more than 60% in Taiwan 
(China) (24-26).
  In conclusion, approximately 10% of CCA cases are estimated 
due to infection with C. sinensis (12% for males, 6% for females). 
In contrast, C. sinensis infection causes a quarter of CCA cases in 
the endemic area. Even though the control of C. sinensis is suc-
cessful due to very effective chemotherapy using praziquantel, 
CCA risk has been continuously increasing, particularly in areas 
hyper-endemic for C. sinensis infection. A more straightforward 
policy for the prevention of C. sinensis infestation that includes 
health education to avoid repeated consumption of raw fresh-
water fish and an extensive effort for early detection targeting 
those who are currently or have been infected with C. sinensis 
in endemic areas is strongly needed.
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